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Background: Natural killer (NK) cells are abundant in the liver and constitute a major innate immune component
that contributes to immune-mediated liver injury. However, few studies have investigated the phenotypes and
functions of NK cells involved in hepatitis B related liver failure (LF), and the precise mechanism underlying NK cell
regulation is not fully understood.
Methods: We detected the percentage and function of peripheral NK cells both in hepatitis B related LF patients
and healthy volunteers by flow cytometry and isolated the liver myofibroblasts (LMFs) from hepatitis B related LF
livers. To determine the possible effects of LMFs on NK cells, mixed cell cultures were established in vitro.
Results: We found a down-regulated percentage of peripheral NK cells in hepatitis B related LF patients, and their
NK cells also displayed decreased activated natural cytotoxicity receptors (NCRs) and cytokine production. In a
co-culture model, LMFs sharply attenuated IL-2-induced NK cell triggering receptors, cytotoxicity, and cytokine
production. The inhibitory effect of LMFs on NK cells correlated with their ability to produce prostaglandin (PG) E2.
Conclusion: These data suggest that LMFs may protect against immune-mediated liver injury in hepatitis B related
LF patients by inhibiting NK cell function via PGE2.
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Liver failure (LF) has a very high mortality rate due to
the loss of functional liver mass below a critical level [1].
The loss of liver functions, such as detoxification, meta-
bolic and regulatory activities, may cause severe compli-
cations, including hepatic coma, systemic hemodynamic
dysfunction and multi-organ failure [1-3]. Hepatitis B re-
lated LF is the most common severe disease requiring
immediate hospitalization in China [4]. Although the* Correspondence: linshumei123@126.com; zhilianggao@21cn.com
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are not fully understood, evidence suggests that the
immune response is involved in the pathogenesis of liver
injury [2].
Natural killer (NK) cells are a fundamental component
of the innate immune system, and they play an import-
ant role in the first-line defense against viral infections
and tumor transformation without prior sensitization
[5-7]. Hepatic NK cells which represent 20%-30% of liver
lymphocytes, are located in the liver sinusoids and are
adherent to the endothelium [8-10]. Increasing evidence
suggests that NK cells play a pivotal role in the patho-
genesis of liver injury, thus contributing to LF. Hepatic
NK cells can directly induce hepatocyte injury through
the surface expression of death ligands (TRAIL/TRAIL
receptor, Fas/Fas ligand and NKG2D/NKG2D ligand)
and the release of perforin [11-14]. The production ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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another important mechanism contributing to liver injury,
which occurs through the induction of hepatocyte apop-
tosis and activation/recruitment of other immune effector
cells [12,15,16]. However, few studies have investigated the
phenotypes and functions of NK cells involved in hepatitis
B related LF, and the precise mechanism underlying NK
cell regulation is not fully understood.
Fibroblasts are ubiquitous cells that provide more than
a source of scaffolding on which other cells function and
migrate. Fibroblasts play an important role in initiating
inflammation via leukocyte recruitment to the site of
tissue injury [17]. Moreover, recent research has re-
ported that fibroblasts isolated from different tumors
can modulate T or NK cell functions [18,19]. Following
hepatic injury, the liver stroma undergoes extensive re-
modeling by liver myofibroblasts (LMFs) that are princi-
pally derived from activated hepatic stellate cells (HSCs)
[20,21]. LMFs can release cytokines and chemokines,
such as IL-6, IL-12, HGF, VEGF and CXCL8, to promote
the recruitment and positioning of lymphocytes in the
inflamed liver as well as affect immune responses [22].
In a murine study, it was shown that activated HSCs at-
tenuated intrahepatic T cell activation [23,24]. However,
few studies have focused on the effect of LMFs from
hepatitis B related LF patients on NK cells.
In the present study, we found that the percentage of
peripheral NK cells was down-regulated with dysfunc-
tion in hepatitis B related LF patients. Our study also con-
sistently showed that LMFs inhibited the IL-2-induced
up-regulation of NK cell triggering receptors, cytokine pro-
duction and cytotoxicity via prostaglandin (PG) E2 produc-
tion in vitro using a cell-cell direct interaction model. Our
research may provide novel insight into the pathogenesis of
hepatitis B related LF.
Methods
Patients and specimens
Liver tissues and peripheral blood were all obtained from
patients in the medical center of Sun Yat-sen University
as described in our previous report [25]. Blood were
from 20 patients with hepatitis B induced liver failure
(Additional file 1: Table S1) and 20 healthy individuals
as controls; diseased liver tissues were from 4 patients
undergoing transplantation for hepatitis B induced LF
(Additional file 1: Table S1); healthy livers were from 3
patients undergoing surgery for hepatic hemangioma;
normal skin fibroblasts (NFs) were from 2 patients
undergoing circumcision. All the samples were anonym-
ously coded in accordance with the local ethical guide-
lines, as stipulated by the Declaration of Helsinki.
Written informed consent was obtained from the pa-
tients, and the protocol was approved by the Review
Board of Sun Yat-sen University.Isolation and culture of fibroblasts
NFs and LMFs were isolated as described previously
[25]. Briefly, 50 grams of liver tissue or 20 grams of fore-
skin sample was diced and digested using type-I collage-
nase (100 U/mL; GIBCO, USA) and hyaluronidase (125
U/mL; Sigma-Aldrich, St. Louis, MO) followed by mech-
anical homogenization in a Stomacher 60 Circulator
(Seward, NY, USA). The cell suspensions derived from
liver specimens were cultured in DMEM medium plus
10% FBS (GIBCO, USA). Fibroblasts that had been pas-
saged for up to 3-8 passage doublings were used for sub-
sequent experiments to minimize clonal selection and
culture stress, which can occur during extended tissue
culture.
Immunofluorescence
LMFs were cultured in 48-well flat-bottom plates. When
the cells were approximately 50% confluent, they were
fixed with 100% carbinol (15 minutes), rinsed and pre-
wetted with phosphate-buffered saline (PBS) prior to the
addition of mouse anti-human monoclonal antibodies
(mAbs)-vimentin, fibronectin and α-smooth muscle
actin (α-SMA), rabbit anti-human mAb-fibroblast sur-
face protein (FSP) and immunoglobulin (IgG) controls
in Tris-buffered saline (pH 7.4) for 60 minutes. The
mAbs were all purchased from Abcam (Cambridge, MA,
USA). The cells were washed and incubated for 30 mi-
nutes in isotype-relevant donkey anti-mouse or anti-
rabbit fluorescein-isothiocyanate-conjugated secondary
antibodies (IgG-AF555 or IgG-AF488, respectively; Mo-
lecular Probes, Carlsbad, CA), and the nuclei were coun-
terstained with 40-6-diamidino-2-phenylindole (Sigma
Aldrich, St. Louis, MO, USA). The images were viewed
and assessed using a fluorescence microscope (LEICA
DMI 4000B; Germany) at 488 nm and analyzed with
Leica Application suite software (version 4.0).
Immunohistochemistry
Paraffin-embedded samples were cut into 5 μm sections
and processed for immunohistochemistry according to
Kuang et al. [26]. Following incubation with anti-CD56Ab
and α-SMA (Abcam, Cambridge, MA), the sections were
stained using the Envision System with diaminobenzidine
(DakoCytomation, Glostrup, Denmark).
Isolation of NK cells
To obtain purified NK cells, peripheral blood mono-
nuclear cells from healthy donors were first isolated via
density gradient centrifugation, according to Pradier
et al. [27], and magnetic active cell sorting (Miltenyi Bio-
tec GmbH, Bergisch Gladbach, Germany) was subse-
quently used to obtain NK cells. Only the populations
displaying more than 90% CD56+CD3- NK cells were
selected.
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NK cells from healthy donors were cultured in RPMI-
1640 plus 10% FBS in 48-well flat-bottom microtiter
plates (5 × 104 cells per well) in the absence or presence
of fibroblasts (NK:fibroblast ratio, 2.5:1), and 100 IU/mL
rhIL-2 (R&D systems, Oxford, United Kingdom) was
added when indicated. At the indicated time intervals,
NK cells were harvested, counted and analyzed. When
indicated, 0.5 mM 1-methyl-tryptophan (Sigma, St. Louis,
MO, USA) and/or 5 μM NS398 (Cayman Chemicals, Ann
Arbor, MI, USA) were added at the onset of the co-
cultures.Flow cytometry analysis
Mouse anti-human mAbs against CD73, CD56, CD69,
NKp44, NKp30, NKp46, NKG2D, DNAM-1 and gran-
zyme B were purchased from BD Biosciences (San Jose,
CA, USA), mouse anti-human mAbs against CD105,
CD90, CD13, CD44, CD31, CD34, CD45 and CD3 were
purchased from eBioscience (San Diego, CA, USA) and
mAbs against TNF-α, IFN-γ and perforin were obtained
from Beckman Coulter (Fullerton, CA, USA) and Biolegend
(San Diego, CA, USA).
The cells were collected, washed, and resuspended in
PBS supplemented with 1% heat-inactivated FBS. There-
after, the cells were directly stained extracellularly with
2 μg mAb in a total staining volume of 100 μL per 106
cells. The cells were stimulated at 37°C for 4 hours with
Leukocyte Activation Cocktail (BD Pharmingen, San
Jose, CA, USA) and fixed and permeabilized prior to
intracellular staining using Pharmingen's staining proto-
col. The data were acquired on a Gallios instrument
(Beckman Coulter, Brea, CA, USA) and analyzed with
FlowJo software.Cytotoxicity assays
The NK cells were tested for cytolytic activity via killing
assays. Briefly, the purified NK cells derived from healthy
donors were cultured with rhIL-2 in the presence or ab-
sence of fibroblasts. K562 cells were used as target cells
(a generous gift from Dr. Dongjun Lin, Leukemia Research
Institute of Sun Yat-sen University) and cocultured with
NK cells for 2 hours at 37°C in 96-well V-bottom plates
(2 × 104 K562 cells per well). Thereafter, the target cells
were stained with 5 μL annexin V (AV)-FITC and propi-
dium iodide (PI), according to Kurschus et al. [28], and in-
cubated in the dark for 15 minutes at room temperature.
The cells were analyzed using multicolor flow cytometry
(FACS Vantage-SE, BD Immunocytometry Systems, San
Diego, CA, USA). Apoptotic and dead cells were identified
by annexin V and PI staining. The lytic potential of the
NK cells was tested by plating cells at different effector-to-
target cell (E/T) ratios.ELISA
Supernatants were generated by seeding 5 × 104 cells per
well into 48-well plates in 500 μL of RPMI-1640/1% bovine
serum albumin (BSA) containing 2 mmol/L L-glutamine,
60 μg/mL benzylpenicillin and 100 μg/mL streptomycin
(all purchased from Sigma Aldrich, St. Louis, MO, USA).
The conditioned culture supernatants were collected and
analyzed for the presence of PGE2 by specific ELISA kits
according to the manufacturer’s instructions (R&D sys-
tems, Abingdon, UK).Western blotting
The fibroblasts were cultured for 5 days in RPMI-1640
supplemented with 10% FBS and 100 U/mL rhIL-2 in
24-well cell culture cluster flat-bottom plates (2.5 × 105
cells per well) in the absence or presence of NK cells
(NK:fibroblast ratio, 2.5:1). Equal amounts of cellular
protein were separated by 10% SDS-PAGE, immuno-
blotted with Abs against COX-2 (Abcam, Cambridge,
MA, USA) and β-actin (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA) and visualized with an ECL kit.Statistical analysis
Multiple comparisons were made between the different
groups via the Mann-Whitney U test. All of the calcula-
tions were performed using Prism software (release 5.00,
GraphPad Software, San Diego, CA, USA). A value of
P <0.05 was considered statistically significant.Results
The percentage of peripheral NK cells are decreased with
dysfunction in hepatitis B related LF patients
To better understand the potential role of NK cells in
the pathogenesis of hepatitis B related LF, we first de-
tected the distribution and phenotype of peripheral NK
cells in these patients. We dissected the subtypes of per-
ipheral blood leukocytes in 20 hepatitis B related LF pa-
tients and 20 healthy controls by flow cytometry analysis
for CD56+CD3- NK cells and CD3+ T cells. In compari-
son with healthy control subjects, the percentages of NK
cells and CD3+ T cells were significantly reduced in
hepatitis B related LF patients (Figure 1A and B). We
further analyzed the expression of NK activation markers,
including NKp30, NKp44, NKp46, NKG2D, DNAM-1,
CD69, cytolytic granules (perforin and granzyme B) and
cytokine (IFN-γ) production by NK cells in the two groups
of individuals. As illustrated in Figure 1C and D, the ex-
pression of most of the activation markers was down-
regulated except for NKG2D and NKp46, and cytolytic
granules and IFN-γ production were inhibited in the per-
ipheral NK cells of hepatitis B related LF patients, suggest-
ing their dysfunctional status.
Figure 1 The variation in peripheral blood NK cells between hepatitis B related LF patients and healthy controls. (A) Representative dot
plots of CD3+ and CD56+ staining in PBMCs isolated from healthy control subjects (HC) and hepatitis B related LF patients (LF). The total number
of 1 × 105 cells per gate was analyzed. The values in the quadrants represent the percentages of CD3-CD56+ NK cells, CD3+CD56+ NKT cells,
CD3+CD56- T cells, and CD3-CD56- cells. (B) The summarized data show the percentages of CD3-CD56+ NK cells and CD3+ T cells in HC and LF.
(C) CD3-CD56+ NK cells were gated. Representative primary FACS histograms depict the expression of activation markers, including NKp30,
NKp44, NKp46, NKG2D, DNAM-1, CD69, cytolytic granules (perforin and granzyme B) and cytokine (IFN-γ) production by peripheral NK cells from
LF (open profiles with solid lines) and HC (gray filled profiles). Open profiles with dotted lines show the isotype control. (D) Pooled data show the
MFI of peripheral NK cells expressing activation receptors, as well as perforin, granzyme B and IFN-γ production from HC (open profiles) and LF
(black profiles). The values given in B and D represent the means ± SEM of five separate experiments. *P <0.05 and **P <0.01 indicate significant
differences between HC and LF (B and D).
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hepatitis B related LF patients
During chronic liver injury, LMFs contribute to tissue
repair alongside regions of cellular damage [29]. How-
ever, it is unclear whether LMFs play a role in acute liver
injury. As shown in Figure 2A, the α-SMA expression
was detectable in patients with acute hepatitis B related
LF, suggesting the same physiologic response of LMFs
during different conditions of liver injury. To further
elucidate the roles of LMFs in hepatitis B related LF, weexamined the infiltration of hepatic CD56+ NK cells and
α-SMA+ LMFs (Figure 2A and B). Interestingly, the NK
cells colocalized with the LMFs at sites of liver inflam-
mation (Figure 2B).
The characteristics of LMFs
To determine the specific effect of LMFs on NK cells,
we first established highly purified subsets of LMFs. The
LMFs were established from the liver tissues of 4 hepatitis
B related LF patients as mentioned above in material
Figure 2 Co-localization of LMFs and NK cells in hepatitis B related LF patients and phenotypic characterization of LMFs. (A) CD56+ NK cells
infiltrate the diseased liver tissues (bar, 100 μm), and a high level of α-SMA is expressed in both chronic (CLF) and acute (ALF) hepatitis B related LF
patients (bar, 200 μm). 1 of 15 representative micrographs is shown. (B) Confocal immunofluorescence shows that CD56+ NK cells are in close proximity
to LMFs (α-SMA+) at the sites of liver inflammation, and 1 of 15 representative micrographs is shown. Bar, 50 μm. (C) Immunofluorescence staining of
LMFs isolated from representative samples of LF patients. Bar, 20 μm. (D) The surface markers of LMFs cultured for 3-5 population doublings were
analyzed by flow cytometry (open profiles, isotype; black filled profiles, stained with indicated Abs). The percentage of positive cells is shown.
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lyzed by immunofluorescence and flow cytometry. The
cultures were of high purity, had the characteristic spindle-
shape, and expressed fibroblast markers (α-SMA, vimentin,
FSP, and fibronectin; Figure 2C). We subsequently used
flow cytometry to determine the purity of LMFs cultured
in vitro. As shown in Figure 2D, all the LMFs expressed
fibroblast markers (CD73, CD90, CD13, CD44 and
CD105) and failed to express endothelial, hematopoietic or
epithelial cell markers (CD31, CD45 and CD34).
LMFs trigger NK cell dysfunction in vitro
We next sought to determine whether LMFs were able
to regulate NK cell phenotypes and functions. NK cellsfreshly isolated from the circulation of healthy donors
were cultured in the absence or presence of rhIL-2. After
5 days of culture, the expression of NK cell triggering re-
ceptors (including NKp46, NKp30, NKp44, NKG2D and
DNAM-1) and the CD69 activation marker was signifi-
cantly up-regulated in the presence of rhIL-2 (Figure 3A).
In addition, the release of cytolytic granules (perforin and
granzyme B) and the secretion of cytokines (TNF-α and
IFN-γ) were up-regulated by rhIL-2 treatment (Figure 3A).
To determine the possible effects of LMFs on NK
cells, mixed cell cultures were set up. Because LMFs do
not exist in healthy livers, and primary HSCs undergo
rapid activation in in vitro culture conditions, we used
NFs as controls as used by other investigators [22].
Figure 3 LMFs regulate NK cell function. NK cells were cultured in rhIL-2 alone or with the indicated fibroblast cells and analyzed by flow
cytometry. (A) After 5 days of culture in the absence or presence of rhIL-2, the triggering receptors, cytolytic granules and cytokine production of NK
cells were analyzed. (B) The expression of NK cell triggering receptors was analyzed. (C) Intracytoplasmic analysis of granzyme B and perforin
expression. (D) Analysis of the production of IFN-γ and TNF-α by NK cells under different conditions. (E) LMF-conditioned NK cells showed reduced
cytotoxicity against K562 cells at different T/E ratios. The mean fluorescence intensities (MFI; indicated as the mean ± SEM of 7 independent
experiments; A, B and C) and the percentages of positive cells (D) or apoptotic cells (E) are shown. The open profiles with dotted lines show the
isotype control, and the open profiles with solid lines show the expression of the indicated markers.
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up-regulation of NKp30, DNAM-1, NKp44 and NKG2D
receptors, while no inhibitory effect could be detected
on NKp46 and CD69. In contrast, NK cells had only a
marginal decrease in the expression of NKp30 and
DNAM-1 upon co-culture with NFs (Figure 3B). Inter-
estingly, the LMFs significantly inhibited the rhIL-2-
induced up-regulation of perforin, while the effect on
granzyme B secretion was slight (Figure 3C). Moreover,
the LMFs significantly interfered with the NK cell secre-
tion of TNF-α and IFN-γ, while the NFs had almost no
effect (Figure 3D).
The down-regulation of perforin and granzyme B ex-
pression in NK cells exposed to LMFs suggests an
impairment in NK cytotoxicity. Therefore, our next en-
deavor was to determine the lytic potential of NK cells
in response to LMFs. Purified NK cells (Medium) or NK
cells that had been cultured with LMFs (LMF) or NFs
(NF) were incubated with K562 cells in the presence of
rhIL-2 at various effector-to-target cell ratios. Consistent
with our hypothesis, as shown in Figure 3E, the cytotox-
icity of the NK cells against K562 cells was remarkably
attenuated upon co-culture with LMFs (E/T = 4:1, 35 ± 3
vs. 27 ± 4; E/T = 8:1, 48 ± 2 vs. 35 ± 5). In contrast, the co-
culture with NFs had no effect on the NK cytotoxicity.
Both cell-cell interactions and soluble factor(s) are involved
in the inhibitory effect of LMFs on NK cells
In an attempt to investigate whether the cell-cell contact
between NK cells and LMFs was responsible for the in-
hibitory effects of LMFs, co-culture experiments were
performed in transwells. As shown in Additional file 2:
Figure S1, the inhibitory effect of LMFs on the expres-
sion of NKp30 under transwell conditions was still
apparent, although reduced, while the expression of
DNAM-1 and NKG2D was minimally affected. These re-
sults suggest that LMFs constitutively release soluble fac-
tor(s) capable of interfering with NKp30 up-regulation.
Such release would be significantly enhanced by the direct
interaction between LMFs and NK cells. In contrast, the
inhibition of DNAM-1 and NKG2D expression appears to
be dependent on cell-cell contact.
PGE2 release is involved in the inhibitory effect of LMFs
on NK cells
It has been reported that PGE2 is the primary fibroblast-
derived immunoregulatory factor [19]. To determine the
role of PGE2 in the NK/LMF co-culture system, culture
supernatants were harvested, and the concentrations of
PGE2 were measured by ELISA. As shown in Figure 4A,
the supernatants derived from LMFs alone contained
PGE2, indicating their spontaneous release. Importantly,
PGE2 release by LMFs was greatly enhanced in the pres-
ence of NK cells (Figure 4A), which suggests thatbidirectional communication between LMFs and NK
cells may contribute to the increased release of PGE2.
Subsequently, LMF proteins were harvested and analyzed
by Western blotting for cyclooxygenase 2 (COX-2), which
is an inducible enzyme involved in the production of PGs
during inflammation. Consistent with the above results,
LMFs spontaneously released large amounts of COX-2,
while NFs produced low levels of COX-2. After co-culture
with NK cells, the production of COX-2 by LMFs was
markedly increased (Figure 4B).
To further confirm the effect of PGE2 on NK cells, co-
culture experiments were performed in the presence or
absence of the PGE2 inhibitor NS398. The addition of
NS398 to the co-culture largely restored the expression
of NKp30, DNAM-1 and NKG2D, and the secretion of
IFN-γ and TNF-α was partially restored (Figure 4C and
D). In contrast, the IDO inhibitor, 1-methyl-tryptophan
(1MT), had almost no effect on the restoration of NK
cell dysfunction (a slight effect was detected only when
used in combination with NS398). Consistent with these
findings, cytotoxicity assays showed that blocking PGE2
largely restored the ability of NK cells to induce the
apoptosis of K562 cells (Figure 4E).
Discussion
In the present study, we provide evidence that LMFs iso-
lated from hepatitis B related LF patients interfere sub-
stantially with the activation of NK cells in vitro. We
show that LMFs attenuated rhIL-2-induced NK cell trig-
gering receptors, cytotoxicity and cytokine production.
This suppressive function, which is largely dependent on
PGE2 release, appears to be specifically induced by
LMFs; NFs had a minimal effect on NK cells and re-
leased low levels of PGE2.
In the current study, we observed that NKp30 were
expressed at lower levels on peripheral NK cells in hepa-
titis B related LF patients compared to healthy controls
(P = 0.0201). However, Zou Y et al. reported up-
regulated NKp30 expression on peripheral NK cells in
patients with HBV-related acute-on-chronic LF [12].
The controversy regarding NKp30 expression on NK
cells of LF patients may derive from the use of different
controls and the complexity of the disease. Firstly, the
controls in our study were all from healthy donors, but
in the report by Zou Y et al., all the controls were from
chronic hepatitis B patients. Secondly, all the samples in
our study were from patients with late stage LF, which
means that the patients were preparing for liver trans-
plantation. However, in the report by Zou Y et al., the
conditions of the patients appeared improved, and they
may have recovered as a result of conservative treat-
ments. We speculate that at the early stage of liver
injury, NK cells may be activated and accelerate inflam-
mation, but at the late stage of liver disease, the function
Figure 4 (See legend on next page.)
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Figure 4 Role of PGE2 in the immunoregulatory effect of LMFs on NK cells. NK cells were co-cultured with LMFs in the absence or presence
of the indicated inhibitors for 5 days with rhIL-2. (A) NK cells were left untreated except for rhIL-2 (NK) or were cultured with the indicated fibroblasts
(NF, normal skin fibroblasts; LMF, LMFs) for 5 days. The concentrations of PGE2 (pg/mL) in the supernatants were assessed by ELISA. (B) The expression
of COX-2 by the above-mentioned cells were assessed by Western blotting. (C) The variations in NKp30, DNAM-1 and NKG2D in the presence of the
indicated inhibitors. (D) The secretion of IFN-γ and TNF-α by NK cells was affected by inhibitors. (E) LMF-conditioned NK cells showed restored
cytotoxicity against K562 cells with the inhibitors. The mean fluorescence intensities (MFI; indicated as the mean ± SEM of 7 independent experiments)
(C) and the percentages of receptor-positive cells (D) or apoptotic cells (E) are shown. The open profiles with dotted lines show the isotype control,
and the open profiles with solid lines show the expression of the indicated markers. *P<0.05, **P<0.01.
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evidence that the cytolytic activities of NK cells increase
during HBV-related spontaneous “hepatic flares” (the early
stage of liver injury) [14,30] and that NK cell functions are
suppressed during advanced liver injury [31].
We studied differentiated LMFs isolated directly from
different diseased human livers. There were no consist-
ent differences between the LMFs isolated from patients
with hepatitis B related LF, and all the LMFs expressed
similar markers and could secrete similar levels of PGE2
(data not shown). Interestingly, the HSCs from healthy
livers could also be activated into LMFs through in vitro
culture, and no differences were found in their levels of
PGE2 secretion (Additional file 3: Figure S2), suggesting
their stability for further research. Consistent with our
results, other investigators have recently reported that
LMF preparations from diseased livers of different eti-
ologies secreted similar patterns of proinflammatory cy-
tokines and chemokines [22].
The present investigation provides evidence that LMFs
can regulate NK cell activation in vitro. Hepatic NK cells
are comparable to in vitro IL-2-activated NK cells de-
rived from the spleen or blood and are thus considered
to be naturally activated by the hepatic microenviron-
ment [32]. Therefore, we used IL-2-stimulated NK cells
isolated from the peripheral blood of healthy donors for
our cultures. With respect to the mechanisms of inhib-
ition, we showed that the NK cell activation receptors,
including NKp30, DNAM-1, NKp44 and NKG2D, were
partially inhibited when exposed to LMFs. Indeed, the
surface expression of CD69 and NKp46 was not inhib-
ited upon LMF co-culture in the study. We believe that
the effect of LMFs on NK cells did not involve a general
blockade of NK cell activation. Consistent with our find-
ings, investigators have reported that the surface expres-
sion of CD69 and NKp46 that are either up-regulated
(NKp46) or induced ex-novo (CD69) after exposure to
IL-2 was not inhibited by the interaction with tumor-
associated fibroblasts [19]. Elucidating the molecular
mechanisms of action by LMFs on NK cells is an inter-
esting and ongoing research project in our laboratory.
Under co-culture conditions, NFs, which don’t release
PGE2, also inhibit the expression of NKp30 and DNAM-1
on NK cells (albeit to a lesser extent). This was consistentwith previous observations and suggested that fibroblasts,
which are rather numerous in organisms, may represent a
cell population that is underrated for its involvement in
immunomodulation [33]. In a recent study, we observed
that NFs could also release different soluble factors [34].
We accept that it is highly likely that other soluble factors
may also be responsible for fibroblast-induced immuno-
suppression on NK cells. However, we argue that PGE2 is
likely to represent a driver of inhibition on NK cells.
In the current study, we observed that LMFs produced
more PGE2 when they were in contact with NK cells,
which in turn led to dysfunctional NK cells. These data
suggest a negative feedback mechanism involving the
LMF-PGE2-NK cell axis. The downregulation of NK cell
function during liver injury may facilitate liver regener-
ation and prevent further hepatocyte injury [10]. How-
ever, accumulating evidence supports an antifibrotic role
for NK cells via the inhibition of HSCs by apoptosis and
IFN-γ production [35-37]. Therefore, the dysfunction of
NK cells during liver injury may facilitate liver fibrosis
or cirrhosis [38]. Simultaneously, decreased NK cell ac-
tivity in cirrhotic patients has been related to an in-
creased incidence and invasiveness of hepatocellular
carcinoma [38,39]. The tumor cells may escape from NK
cell immune surveillance and directly and indirectly fa-
cilitate tumor progression and metastasis [40]. There-
fore, we believe that LMFs are double-edged swords.
The precise mechanisms underlying the deterioration
of liver function during hepatitis B related LF remain
unclear. However, the impairment of cellular immunity
is believed to be a contributing factor. In general, acti-
vated NK cells accelerate liver injury by producing pro-
inflammatory cytokines, such as granzyme B and IFN-γ,
and by killing hepatocytes [41]. Moreover, the function
of NK cells can be further enhanced by other cytokines,
such as IFN-γ, IL-8, IL-12 and IL-15 [14,30]. The induc-
tion of PGE2 by LMFs may represent a mechanism of
limiting liver damage, such that few patients with fibrosis
develop fulminant LF [42]. Consistent with our results, a
recent study reports that liver fibrosis may be protective in
the context of acute liver injury [43]. We hypothesize that
NK cells may be inhibited and preferentially skewed to-
ward suppression activity during hepatitis B related LF, de-
pending on the balance between the levels of PGE2 and
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fore warranted to determine the hypothesis.
Our study has limitations. First, most of our experi-
ments were done in vitro, which may not stand for the
in vivo state of hepatitis B related LF patients. Neverthe-
less, our study is of hypothesis-generating value for the
design of future in vivo studies. Second, the 20 patients
from whom serum was studied and the 4 liver tissues of
subjects with hepatitis B related LF are not representa-
tive for all phases of LF and these numbers are small
with respect to the different conditions of these LF pa-
tients. In China, hepatitis B is involved in more than
80% of LF cases due to a high incidence of HBV infec-
tion, and most LF patients died except for liver trans-
plantation [44]. However it is very difficult to obtain
sufficient quantities of liver tissue from these kind of pa-
tients for the shortage of donor organs. Nonetheless,
since there were no consistent differences that character-
ized LMFs isolated from different hepatitis B related LF
patients in our study, we believe that this phenomenon
is not peculiar to a few patients and as seems more likely
applicable to most LF patients. Despite these shortcom-
ings, we believe our analysis shows the role of LMFs in
the regulation of NK cell functions during the process of
hepatitis B related LF. Larger studies are necessary to
fully address this important question.
In conclusion, LMFs not only regulate remodeling
against liver injury by producing the extracellular matrix
but also release PGE2, which can regulate immune re-
sponses. The notion that NK cells can trigger a paradox-
ical suppressive loop by enhancing the release of PGE2
by LMFs in vitro reveals an interesting area of investiga-
tion for the field of immune subversion in hepatitis B re-
lated LF patients. Indeed, this observation suggests that
LMFs not only suppress NK cells but may also interact
with them, thereby eliciting reciprocal cross-talk to pro-
tect hepatocytes from further injury. Further studies
should be performed to extend our knowledge on this
matter in view of the attempts to exploit NK cell-based
cellular therapies [45].
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